Overview

Treatment of Primary CNS Lymphoma

Status:
Unknown status

Trial end date:
2020-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of FVD regiment (fotemustine, teniposide and dexamethasone ) for patients with primary CNS lymphoma.

Phase:

Phase 4

Details

Lead Sponsor:

Mingzhi Zhang

Collaborator:

Zhengzhou University

Treatments:

Cytarabine
Fotemustine
Teniposide